Diopsys Funding: How Much Did They Raise & Key Investors

How Much Did Diopsys Raise?
Funding & Key Investors

Diopsys has secured significant capital, with its total funding reaching $350K. The company recently announced a major strategic investment of $350K, underscoring its progress in the vision diagnostics sector. This latest financing round is indicative of Diopsys's advanced stage of development and its strategic positioning within the healthcare technology market.

What is Diopsys?

Diopsys

Manufacturing

Medical Devices & Equipment

Diopsys USA is a specialized entity focused on vision testing systems, most notably its NOVA Vision Testing System. The company's product portfolio includes Visual Evoked Potential (VEP) testing, available in the U.S. and select international markets, alongside Electroretinography (ERG) testing, which is exclusively offered outside the U.S. Diopsys aims to equip healthcare professionals and institutions with advanced diagnostic tools for comprehensive vision care.

How much funding has Diopsys raised?

Diopsys has raised a total of $350K across 1 funding round:

2020

Debt

$350K

Debt (2020): $350K with participation from PPP

What's next for Diopsys?

The substantial capital infusion, highlighted by the $350K in total funding and the recent $350K strategic investment, positions Diopsys for accelerated growth and market expansion. This late-stage financing suggests a focus on scaling operations, enhancing product development, and potentially broadening its market reach, particularly for its ERG technology in international territories. The company is poised to further solidify its standing in the competitive vision diagnostics landscape.

See full Diopsys company page

See More Financial Insights